[SCHEDULE 13D/A] CF BANKSHARES INC. SEC Filing

Rhea-AI Filing Summary

Castle Creek Capital Partners VII, LP amended its Schedule 13D to report recent sales of CF Bankshares Inc. (CFBK) common stock. Between September 23, 2025 and October 6, 2025, Fund VII sold an aggregate of 70,621 shares for proceeds of $1,714,153.61 in multiple open-market, broker-assisted transactions. After these sales, Fund VII holds 537,600 shares, representing approximately 8.4% of the Voting Common Stock, calculated on a base of 6,370,807 shares outstanding. The filing lists the daily volumes and weighted average prices for each sale date, ranging roughly between $24.00 and $24.98 per share. Castle Creek Capital VII LLC is disclosed as having shared voting and dispositive power with respect to these shares.

Positive

• Maintained a significant stake of 537,600 shares (~8.4%) after sales
• Transparent disclosure of per‑day share sales and weighted average prices

Negative

• Reduced position by 70,621 shares, representing a cash outflow to the market of $1,714,153.61
• Ownership fell from prior levels (implied by the sales), which could reduce influence over corporate actions

Insights

Equity Ownership Analyst

Fund reduced position modestly while retaining a meaningful stake.

Fund VII sold 70,621 shares for $1.71M but still holds 537,600 shares, about 8.4% of the voting class. The remaining stake is large enough to be influential but below a controlling threshold.

The sales occurred over multiple days at prices mostly near $24.00, suggesting routine liquidity-driven disposition rather than a single block trade; monitor future amendments for further changes in percentage ownership over the next quarter.

Transaction & Market Microstructure Specialist

Transactions appear as broker-assisted open-market sales at narrow price ranges.

Reported weighted-average prices per date range from $24.00 to $24.98, indicating execution across tight intraday spreads. The filing specifies per-day share counts and exact weighted averages, allowing traceability to market activity.

Because proceeds totaled $1,714,153.61, the trades are modest relative to typical institutional positions; watch for further Schedule 13D/A filings if cumulative sales materially change the 8.4% ownership within 60 days.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 17)

CF BANKSHARES INC.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

12520L109

(CUSIP Number)

Deborah Sykes
11682 El Camino Real, Suite 320,
San Diego, CA, 92130
858-756-8300

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

10/06/2025

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. 12520L109

1

Name of reporting person

CASTLE CREEK CAPITAL PARTNERS VII, LP

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 537,600.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 537,600.00

11

Aggregate amount beneficially owned by each reporting person

537,600.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

8.4 %

14

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person:

(1) The information set forth in Item 5 of this statement on Schedule 13D is incorporated herein by reference.

SCHEDULE 13D

CUSIP No. 12520L109

1

Name of reporting person

CASTLE CREEK CAPITAL VII LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF, WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 537,600.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 537,600.00

11

Aggregate amount beneficially owned by each reporting person

537,600.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

8.4 %

14

Type of Reporting Person (See Instructions)

HC, OO

Comment for Type of Reporting Person:

(1) The information set forth in Item 5 of this statement on Schedule 13D is incorporated herein by reference.

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock, par value $0.01 per share
(b)	Name of Issuer: CF BANKSHARES INC.
(c)	Address of Issuer's Principal Executive Offices: 4960 E. Dublin Granville Road, Suite #400, Columbus, OHIO , 43081.
Item 1 Comment: This Amendment No. 17 to Schedule 13D (this "Amendment No. 17") amends and supplements the Schedule 13D filed on December 24, 2019 (the "Original Schedule 13D", and as amended by Amendment No. 1 filed on March 31, 2020, Amendment No. 2 filed on June 1, 2020, Amendment No. 3 filed on November 26, 2024, Amendment No. 4 filed on December 3, 2024, Amendment No. 5 filed on December 12, 2024, Amendment No. 6 filed on May 14, 2025, Amendment No. 7 filed on May 22, 2025, Amendment No. 8 filed on July 3, 2025, Amendment No. 9 filed on July 10, 2025, Amendment No. 10 filed on July 23, 2025, Amendment No. 11 filed on August 15, 2025, Amendment No. 12 filed on August 26, 2025, Amendment No. 13 filed on August 29, 2025, Amendment No. 14 filed on September 8, 2025, Amendment No. 15 filed on September 10, 2025 and Amendment No. 16 filed on September 23, 2025, the "Schedule 13D") with the U.S. Securities and Exchange Commission (the "SEC"), relating to the shares of common stock, par value $0.01 per share ("Voting Common Stock"), of CF Bankshares Inc. (formerly known as Central Federal Corporation) (the "Issuer" or the "Company"). Unless specifically amended hereby, the disclosures set forth in the Schedule 13D remain unchanged. Capitalized terms used in this Amendment No. 17 that are not otherwise defined herein have the meanings attributed to them in the Original Schedule 13D.
Item 3.	Source and Amount of Funds or Other Consideration
	Item 3 of the Schedule 13D is hereby amended and supplemented by adding the following: Between September 23, 2025 and October 6, 2025 (inclusive), Castle Creek Capital Partners VII, LP ("Fund VII") sold an aggregate of 70,621 shares of Voting Common Stock for proceeds of $1,714,153.61, which represents an amount net of commissions and fees, in various open-market transactions. Following such transactions, Fund VII owns 537,600 shares of Voting Common Stock.
Item 5.	Interest in Securities of the Issuer
(a)	Item 5(a) and (b) of the Schedule 13D is hereby amended and supplemented as follows: Fund VII owns 537,600 shares of the Voting Common Stock, which represents approximately 8.4%* of the Voting Common Stock. *This calculation is based on 6,370,807 shares of Voting Common Stock of the Company outstanding, which was calculated based on (i) 5,772,207 shares of Voting Common Stock outstanding as of August 4, 2025, as reported in the Company's Quarterly Report on Form 10-Q filed with the SEC on August 8, 2025, and (ii) increased by the 598,600 shares of Voting Common Stock issued to Fund VII upon conversion of an equal number of shares of Non-Voting Common Stock between August 29, 2025 and October 3, 2025, inclusive.
(b)	Fund VII has shared power to vote or direct the vote and shared power to dispose or direct the disposition of the 537,600 shares of Voting Common Stock described above with CCC VII. CCC VII disclaims beneficial ownership of the Voting Common Stock beneficially owned by Fund VII, except to the extent of its pecuniary interest therein.
(c)	Item 5(c) of the Schedule 13D is hereby amended and supplemented as follows: Except as previously disclosed in the Schedule 13D, Fund VII has engaged in the following open market, broker-assisted transactions with respect to the Voting Common Stock during the last 60 days through the date of the event which requires filing of this Schedule 13D: (i) 28,411 shares of Voting Common Stock sold on September 23, 2025 at a weighted average price of $24.53 per share (in multiple open market, broker-assisted transactions ranging from $24.50 to $24.98 per share, inclusive); (ii) 5,163 shares of Voting Common Stock sold on September 24, 2025 at a weighted average price of $24.35 per share (in multiple open market, broker-assisted transactions ranging from $24.30 to $24.63 per share, inclusive); (iii) 914 shares of Voting Common Stock sold on September 25, 2025 at a weighted average price of $24.30 per share (in multiple open market, broker-assisted transactions ranging from $24.30 to $24.32 per share, inclusive); (iv) 9,336 shares of Voting Common Stock sold on September 26, 2025 at a weighted average price of $24.31 per share (in multiple open market, broker-assisted transactions ranging from $24.30 to $24.365 per share, inclusive); (v) 5,256 shares of Voting Common Stock sold on September 29, 2025 at a weighted average price of $24.10 per share (in multiple open market, broker-assisted transactions ranging from $24.10 to $24.135 per share, inclusive); (vi) 9,743 shares of Voting Common Stock sold on September 30, 2025 at a weighted average price of $24.08 per share (in multiple open market, broker-assisted transactions ranging from $24.00 to $24.12 per share, inclusive); (vii) 200 shares of Voting Common Stock sold on October 1, 2025 at a price of $24.00 per share; (viii) 943 shares of Voting Common Stock sold on October 3, 2025 at a price of $24.00 per share; and (ix) 10,655 shares of Voting Common Stock sold on October 6, 2025 at a price of $24.00 per share.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

CASTLE CREEK CAPITAL PARTNERS VII, LP

Signature:	/s/ Tony Scavuzzo
Name/Title:	Tony Scavuzzo, Managing Principal
Date:	10/08/2025

CASTLE CREEK CAPITAL VII LLC

Signature:	/s/ Tony Scavuzzo
Name/Title:	Tony Scavuzzo, Managing Principal
Date:	10/08/2025

FAQ

What did Castle Creek Capital Partners VII sell in the CF Bankshares (CFBK) filing?

Between September 23, 2025 and October 6, 2025, Fund VII sold 70,621 shares of Voting Common Stock in open-market, broker-assisted transactions.

How much cash did the Fund raise from the CFBK share sales?

The aggregate proceeds reported were $1,714,153.61, net of commissions and fees.

What is Castle Creek Fund VII's remaining ownership in CFBK after these sales?

Fund VII holds 537,600 shares, representing approximately 8.4% of the Voting Common Stock based on 6,370,807 shares outstanding.

At what prices were the CFBK shares sold?

Daily weighted average prices ranged from about $24.00 to $24.98, with several trades reported exactly at $24.00.

Who filed and certified this Schedule 13D/A for CFBK?

The filing was signed and certified by Tony Scavuzzo, Managing Principal, on behalf of Castle Creek Capital Partners VII, LP and Castle Creek Capital VII LLC.